InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
EQS-News: invIOs GmbH / Key word(s): Study invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding 05.09.2023 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. invIOs starts further c.
EQS-News: invIOs GmbH: invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.